Janice B Schwartz
Affiliation: University of California
- The influence of sex on pharmacokineticsJanice B Schwartz
Institute on Aging and Jewish Home of San Francisco, and University of California, San Francisco, California 94112, USA
Clin Pharmacokinet 42:107-21. 2003..The relative role of sex on pharmacokinetics as compared to genetics, age, disease, social habits and their potential interactions in the clinical setting is not yet fully known but should be routinely considered and further studied...
- Erythromycin breath test results in elderly, very elderly, and frail elderly personsJanice B Schwartz
Jewish Home of San Francisco and Division of Clinical Pharmacology, Department of Medicine, University of California, San Francisco, California, USA
Clin Pharmacol Ther 79:440-8. 2006..Our objective was to determine the effects of very old age and frailty on erythromycin breath test (ERBT) results in patients and, secondarily, to determine the effects of sex and comedications on ERBT results...
- Gender-specific implications for cardiovascular medication use in the elderly optimizing therapy for older womenJanice B Schwartz
Divisions of Clinical Pharmacology and Cardiology, University of California, San Francisco and Jewish Home of San Francisco, San Francisco, CA 94112, USA
Cardiol Rev 11:275-98. 2003..Optimal care for the older woman with cardiovascular disease will also require investigation of cardiovascular medications in older women and of therapies for cardiovascular diseases that are more common in women than men...
- What does the Medicare prescription drug legislation mean for the American cardiologist?Janice B Schwartz
Jewish Home of San Francisco and the Division of Clinical Pharmacology, University of California, San Francisco, CA 94112, USA
Am J Geriatr Cardiol 14:317-24. 2005..This article details the background, benefits, and expected impact of all of these aspects of the new Medicare Part D prescription drug benefit...
- Preferential enhancement of older human T cell cytokine generation, chemotaxis, proliferation and survival by lenalidomideMei Chuan Huang
Department of Medicine, University of California, San Francisco, CA, USA
Clin Immunol 138:201-11. 2011..The reversal of T cell abnormalities of immunosenescence by low concentrations of lenalidomide suggest a potential for improvement of immunity in the elderly...
- Distinct energy requirements for human memory CD4 T-cell homeostatic functionsDennis D Taub
National Institute on Aging, National Institutes of Health, Baltimore, Maryland, USA
FASEB J 27:342-9. 2013..The sources supplying energy for diverse functions of unactivated T(mem) cells differ from that required for function after immune activation...
- Relationship of vitamin D, HIV, HIV treatment, and lipid levels in the Women's Interagency HIV Study of HIV-infected and uninfected women in the United StatesJanice B Schwartz
Research Department, Jewish Home, San Francisco, CA, USA
J Int Assoc Provid AIDS Care 13:250-9. 2014..Vitamin D deficiency is common irrespective of HIV status but influenced by HIV treatment. Similarly, vitamin D levels were positively related to triglycerides only in ART-treated HIV-infected women and unrelated to cholesterol. ..
- Defective T cell chemotaxis to sphingosine 1-phosphate and chemokine CCL21 in idiopathic T lymphocytopeniaEdward J Goetzl
Department of Medicine, University of California, Geriatric Research Center, San Francisco, CA 94112, USA
J Clin Immunol 31:744-51. 2011..Defective T cell chemotactic responses to S1P and some chemokines may lead to subset-selective abnormal T cell trafficking and chronic T cell lymphocytopenia...
- Vitamin D3 effects on lipids differ in statin and non-statin-treated humans: superiority of free 25-OH D levels in detecting relationshipsLynn Kane
MD, 302 Silver Avenue, San Francisco, CA 94112
J Clin Endocrinol Metab 98:4400-9. 2013..Inverse associations between 25-OH vitamin D levels and cardiovascular morbidity and mortality have been reported...
- Patterns of multimorbidity in elderly veteransMichael A Steinman
Division of Geriatrics, University of California at San Francisco, San Francisco, California, USA
J Am Geriatr Soc 60:1872-80. 2012..To determine patterns of co-occurring diseases in older adults and the extent to which these patterns vary between the young-old and the old-old...
- Gender specificity of altered human immune cytokine profiles in agingEdward J Goetzl
Department of Medicine, University of California, San Francisco, CA 94143 0711, USA
FASEB J 24:3580-9. 2010..38, P<0.05 and 1.62, P<0.01, respectively), whereas ratios of IFN-gamma-evoked IP-10 chemokine were low in all groups. Alterations in immune cytokine profiles with aging show significant gender specificity...
- Age and sex variation in prevalence of chronic medical conditions in older residents of U.S. nursing homesKelly L Moore
Center for Research on Aging of Jewish Home, San Francisco, California, USA
J Am Geriatr Soc 60:756-64. 2012..To investigate patterns in prevalences of chronic medical conditions over the age span of long-term stay nursing home residents and between the sexes with data from the 2004 National Nursing Home Survey (NNHS)...
- Failure of pharmacogenetic-based dosing algorithms to identify older patients requiring low daily doses of warfarinJanice B Schwartz
Jewish Home, San Francisco, CA, USA
J Am Med Dir Assoc 12:633-8. 2011..We evaluated performance of pharmacogenetic-based warfarin dosing estimation algorithms in old and very old patients...
- Population analyses of amlodipine in patients living in the community and patients living in nursing homesDongwoo Kang
Department of Medicine, Division of Clinical Pharmacology, University of California, San Francisco, Calif, USA
Clin Pharmacol Ther 79:114-24. 2006..Our objective was to determine the effects of age, sex, and morbidity on the apparent oral clearance (CL/F) of amlodipine...
- Pharmacogenetics: has it reached the clinic?Janice B Schwartz
Long Term Care Research Center, Institute on Aging Jewish Home, 302 Silver Ave, San Francisco, CA 94112, USA
J Gend Specif Med 5:13-8. 2002..g., 6-mercaptopurine and azathioprine) because clinically life-threatening complications or decreased efficacy is strongly related to the genetically determined activity of this enzyme...
- Sample size computations for PK/PD population modelsDongwoo Kang
Department of Biopharmaceutical Sciences, University of California at San Francisco, 521 Parnassus Avenue, Box 0446, San Francisco, CA 94143 0446, USA
J Pharmacokinet Pharmacodyn 32:685-701. 2005..The method is general and can accommodate any type of hierarchical models. Simulation results suggest that intensive sampling allows the reduction of the number of patients enrolled in a clinical study...
- A sample size computation method for non-linear mixed effects models with applications to pharmacokinetics modelsDongwoo Kang
Department of Biopharmaceutical Sciences, University of California San Francisco, San Francisco, CA 94132 0446, USA
Stat Med 23:2551-66. 2004..The proposed method greatly reduces computing times compared with simulation-based methods of estimating sample sizes for population PK studies...
- Population analyses of sustained-release verapamil in patients: effects of sex, race, and smokingDongwoo Kang
Division of Clinical Pharmacology, Department of Biopharmaceutical Sciences, University of California at San Francisco, San Francisco, USA
Clin Pharmacol Ther 73:31-40. 2003..Our objective was to determine the effects of age, sex, and sustained-release formulation on apparent oral clearance of sustained-release racemic verapamil in patient populations...
- Sudden cardiac death among women in the United StatesJanice B Schwartz
Circulation 108:e153; author reply e153. 2003
- Sex differences in major bleeding with glycoprotein IIb/IIIa inhibitors: results from the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) initiativeKaren P Alexander
Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27715, USA
Circulation 114:1380-7. 2006..The contribution of dosing to the observed sex-related differences in bleeding is unknown...